11 Best Guru Stocks to Buy According to Wall Street Analysts
Wall Street seems to be breathing a little easier after the initial panic over President Trump’s tariffs earlier this month, but the rollercoaster is not over just yet.
Corcept Therapeutics Inc (CORT)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Renaissance Technologies Jim Simons | 6,198,602 | $312,347,555 | -5% | 0.46% |
| 2. | Arrowstreet Capital Peter Rathjens, Bruce Clarke And John Campbell | 1,644,942 | $82,888,627 | +5% | 0.06% |
| 3. | D E Shaw D. E. Shaw | 886,576 | $44,674,565 | +13% | 0.03% |
| 4. | Millennium Management Israel Englander | 508,357 | $25,616,109 | +113% | 0.01% |
| 5. | 500,000 | $25,195,000 | 0.05% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $21.53 | 100,000 | Director | 3,308,303 | 2021-06-11 | Filing | |
| $21.53 | 50,000 | Director | 1,046,838 | 2021-06-11 | Filing | |
| $22.64 | 68 | Director | 3,208,303 | 2020-12-01 | Filing | |
| $22.80 | 1,109 | Director | 3,208,235 | 2020-11-30 | Filing | |
| $22.81 | 361 | Director | 3,207,126 | 2020-11-25 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $70.22 | 2,200 | 0 | 2025-04-10 | Filing | ||
| $114.55 | 590 | 85,622 | 2025-04-01 | Filing | ||
| $102.16 | 5,590 | 85,622 | 2025-03-31 | Filing | ||
| $101.43 | 15,133 | 91,212 | 2025-03-31 | Filing | ||
| $100.26 | 79,277 | 106,345 | 2025-03-31 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 3,972,416 | $219,646,189 | 4.95% | |
| 2. | 584,800 | $66,795,856 | 0.49% | |
| 3. | 201,401 | $23,003,999 | 0.02% | |
| 4. | 228,012 | $20,961,143 | 0.04% | |
| 5. | 170,751 | $19,503,179 | 2.46% |
News See All
Corcept Therapeutics Incorporated (NASDAQ:CORT) Q4 2024 Earnings Call Transcript
Corcept Therapeutics Incorporated (NASDAQ:CORT) Q4 2024 Earnings Call Transcript February 26, 2025Corcept Therapeutics Incorporated misses on earnings expectations.
10 Best Performing Pharma Stocks So Far in 2025
On February 20, Jared Holz, Mizuho healthcare sector strategist, appeared on 'Squawk Box' to discuss the potential challenges and opportunities the pharmaceutical industry may face under the new Trump...
12 Hot Stocks to Buy According to Analysts
While the stock market in the United States remained closed on January 20 for Martin Luther King, Jr. Day, the day was happening with Donald Trump's inauguration on the same date.
15 Best Growth Stocks to Buy for the Next 5 Years
Kevin Mahn, President & CIO at Hennion & Walsh Asset Management, recently appeared on CNBC on January 6 to discuss the current market momentum and emphasize the need for investors to be selective in 2025...
Corcept Therapeutics Incorporated (CORT) Surged on Strong Results and Increased Guidance
ClearBridge Investments, an investment management company, released its “ClearBridge Small Cap Strategy” third quarter 2024 investor letter. A copy of the letter can be downloaded here.
10 Stocks That Will Make You Rich In 2025
Jurrien Timmer, Director of Global Macro at Fidelity Management & Research Company, recently shared his outlook for the stock market in 2025.
Corcept Therapeutics Incorporated (NASDAQ:CORT) Q3 2024 Earnings Call Transcript
Corcept Therapeutics Incorporated (NASDAQ:CORT) Q3 2024 Earnings Call Transcript October 30, 2024Corcept Therapeutics Incorporated beats earnings expectations.
Does Corcept Therapeutics (CORT) Have a Long Runway for Growth?
ClearBridge Investments, an investment management company, released its “ClearBridge Small Cap Value Strategy” second quarter 2024 investor letter. A copy of the letter can be downloaded here.
Corcept Therapeutics Incorporated (NASDAQ:CORT) Q2 2024 Earnings Call Transcript
Corcept Therapeutics Incorporated (NASDAQ:CORT) Q2 2024 Earnings Call Transcript July 29, 2024Corcept Therapeutics Incorporated beats earnings expectations.
Billionaire Hedge Funds
